Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 1997

View Archived Issues

Company Profile: Mercury Therapeutics

Alexion issued two patents covering technology for xenotransplantation products

Viracept now available in Canada through expanded access program

FDA approves Mylan's generic extended-release diltiazem

Roche gains access to combinatorial libraries

Aquila's QS-21 enhances immune response of DNA vaccines in preclinical studies

Smith & Nephew to evaluate DynaGen's Orthodyn

Cel-Sci's HGP-30 AIDS vaccine shows recognition of major HIV subtypes

Nanogen and Becton Dickinson enter diagnostic collaboration

Dermik introduces combination acne therapy in South Africa

Lilly and Scios AD collaboration

Orphan Medical's medicated chewing gum reduces stomach levels of H. pylori

CytoMed initiates phase II trials of CMI-392

Medtronic and Cephalon to copromote Intrathecal Baclofen Therapy

Nippon Shinyaku prepares improved ciclosporin derivatives

Antiparasitic depsipeptides from Meiji Seika

Wakunaga prepares novel antibacterial agents

Lilly discloses selective beta3-agonists

Bradykinin antagonists from Fujisawa

Improved analgesic/antiinflammatory urea derivatives disclosed by Novartis

MS&D reports potent and selective 5-HT1Dalpha agonists

Cinchonine shown to reverse multidrug resistance

Preclinical and preliminary clinical data reported for LU-103793

ONYX-015 demonstrates in vitro and in vivo efficacy

Preclinical data for ZD-1839, an EGF tyrosine kinase inhibitor

BM-92.0700: a promising anticancer clinical candidate

Novel EGF receptor TK inhibitor described by Mitsubishi

Natural cancer immunotherapeutic discovered by Yonsei University researchers

New class of topo I inhibitors designed for oral administration

Anti-HBV/anti-HIV L-nucleoside analogue described

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...